Kyoto, Japan

Tetsuyoshi Sugita


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tetsuyoshi Sugita: Innovator in Ovarian Cancer Detection

Introduction

Tetsuyoshi Sugita is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the identification of epithelial ovarian cancer. His innovative approach focuses on molecular typing, which offers a new perspective compared to traditional histopathology methods.

Latest Patents

Sugita holds a patent for a "Marker for identification of tissue type of epithelial ovarian cancer, and method for determination of the occurrence of epithelial ovarian cancer based on tissue type by using the marker." This patent presents a method for identifying the morbidity of epithelial ovarian cancer based on tissue type. The method involves treating a sample from an individual to detect biological molecules that show specific upregulation or downregulation in expression related to the cancer type. This innovative approach allows for a more accurate identification of the tissue type involved in the disease.

Career Highlights

Throughout his career, Tetsuyoshi Sugita has worked with prominent organizations such as Shimadzu Corporation and Keio University. His experience in these institutions has contributed to his expertise in medical technology and diagnostics. Sugita's work has been instrumental in advancing the understanding and detection of ovarian cancer.

Collaborations

Sugita has collaborated with notable colleagues, including Taka-Aki Sato and Atsuhiko Toyama. These partnerships have fostered a collaborative environment that enhances research and innovation in cancer detection.

Conclusion

Tetsuyoshi Sugita's contributions to the field of ovarian cancer detection through his innovative patent highlight his role as a significant inventor. His work not only advances medical diagnostics but also offers hope for improved patient outcomes in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…